Oramed Pharmaceuticals Files 2024 Annual Report
Ticker: ORMP · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1176309
| Field | Detail |
|---|---|
| Company | Oramed Pharmaceuticals Inc. (ORMP) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, financials
TL;DR
Oramed Pharma dropped its 2024 10-K. Check financials & biz ops.
AI Summary
Oramed Pharmaceuticals Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, incorporated in Delaware, is based in New York, NY, and operates in the pharmaceutical preparations industry. This filing provides a comprehensive overview of the company's financial performance and business operations for the past fiscal year.
Why It Matters
This 10-K filing provides investors and stakeholders with a detailed look at Oramed Pharmaceuticals' financial health and strategic direction for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Oramed is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the reporting period for financial statements.)
- 2024 — Fiscal Year (The period covered by the annual report.)
Key Players & Entities
- ORAMED PHARMACEUTICALS INC. (company) — Registrant
- 2024 (date) — Fiscal Year End
- 1185 Avenue of the Americas, Third Floor, New York, NY 10036 (location) — Principal Executive Offices
- Delaware (location) — State of Incorporation
- 001-35813 (other) — Commission file number
FAQ
What is Oramed Pharmaceuticals Inc.'s primary business activity?
Oramed Pharmaceuticals Inc. is primarily involved in the pharmaceutical preparations industry, as indicated by its Standard Industrial Classification code [2834].
When did Oramed Pharmaceuticals Inc. file its annual report?
Oramed Pharmaceuticals Inc. filed its Form 10-K on March 27, 2025, for the fiscal year ended December 31, 2024.
Where are Oramed Pharmaceuticals Inc.'s principal executive offices located?
The principal executive offices of Oramed Pharmaceuticals Inc. are located at 1185 Avenue of the Americas, Third Floor, New York, NY 10036.
In which U.S. state was Oramed Pharmaceuticals Inc. incorporated?
Oramed Pharmaceuticals Inc. was incorporated in Delaware.
What is the commission file number for Oramed Pharmaceuticals Inc.?
The commission file number for Oramed Pharmaceuticals Inc. is 001-35813.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding ORAMED PHARMACEUTICALS INC. (ORMP).